Modified mRNAs in the Cardiovascular System: A New Platform for Gene Therapy
- PMID: 28550973
- PMCID: PMC5475259
- DOI: 10.1016/j.ymthe.2017.05.011
Modified mRNAs in the Cardiovascular System: A New Platform for Gene Therapy
Comment on
-
Optimizing Cardiac Delivery of Modified mRNA.Mol Ther. 2017 Jun 7;25(6):1306-1315. doi: 10.1016/j.ymthe.2017.03.016. Epub 2017 Apr 4. Mol Ther. 2017. PMID: 28389322 Free PMC article.
References
-
- Xiao P.J., Lentz T.B., Samulski R.J. Recombinant adeno-associated virus: clinical application and development as a gene-therapy vector. Ther. Deliv. 2012;3:835–856. - PubMed
-
- Hajjar R.J., del Monte F., Matsui T., Rosenzweig A. Prospects for gene therapy for heart failure. Circ. Res. 2000;86:616–621. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources